DOI: https://doi.org/10.22141/2224-0551.2.45.2013.88248

Chronic Mucocutaneous Candidiasis as Primary Immunodeficiency in Children

L.I. Chernyshova, A.V. Bondarenko, A.P. Volokha, F.I. Lapiy, V.P. Chernyshov, L. Marodi

Abstract


Chronic mucocutaneous candidiasis is a genetically heterogeneous group of disorders associated with mutations in genes STAT1, IL17RA, IL17F, AIRE, STAT3, TYK2, IL12RB1, and IL12B. Chronic mucocutaneous candidiasis can present as a clinical syndrome in primary and secondary immunodeficiency, or distinct nosological entity of primary immunodeficiency. Today the major components of immunopathology of chronic mucocutaneous candidiasis are defects of immune response, mediated by IL-17 and IL-22. The article describes two cases of chronic mucocutaneous candidiasis, associated with mutations in gene STAT1, in children.


Keywords


chronic mucocutaneous candidiasis; immunodeficiency; children

References


Al-Herz W., Bousfiha A., Casanova J-L. et al. Primary immunodeficiency diseases: an update on the classification from the International Unit of Immunological Societies Expert Committee for Primary Immunodeficiency // Frontiers in Immunology. — 2011. — V. 2, № 54. — P. 1-26.

Gaffen S.L. Recent advances in the IL-17 cytokine family // Current Opinion Immunology. — 2011. — V. 23, № 5. — P. 613-619.

Glocker E-O., Hennigs A., Nabavi M. et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections // N. Engl. J. Med. — 2009. — V. 361. — P. 1727-35.

Hanna S., Etzioni A. New host defencse mechanisms against Candida species clarify the basis of clinical phenotypes // J. Allergy Clin. Immunology. — 2011. — V. 127. — P. 1433-7

Liu L., Okada S., Kong X-F. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis // J. Experimental. Medicine. — 2011. — V. 208, № 8. — P. 1635-1648.

Marodi L., Cypowyj S., Toth B., Chernyshova L. et al. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species // J. Allergy Clin. Immunology. — 2012. — V. 130. — P. 1019-27.

Mazza C., Buzi F, Ortolani F. et al. Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome // Clin. Immunol. — 2011. — V. 139. — P. 6-11.

Netea M.G., Marodi L. Innate immune mechanisms for recognition and uptake of Candida species // Trends Immunology. — 2010. — V. 31. — P. 346-353.

Ochs H.D., Oukka M., Torgerson T.R. Th17 cells and regulatory T cells in primary immunodeficiency diseases // J. Allergy Clin. Immunology. — 2009. — V. 123. — P. 977-83.

Puel A., Cypowyj S., Bustamante J. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity // Science. — 2011. — V. 332, № 6025. — P. 65-68.

Robles D.T. Chronic mucocutaneous candidiasis // www.emedicine.medscape.com

Roifman C.M. Chronic mucocutaneous candidiasis // www.uptodate.com

Van de Veerdonk F.L., Theo S. Plantinga T.S., Hoischen A. STAT1 Mutations in autosomal dominant chronic mucocutaneous candidiasis // N. Engl. J. Med. — 2011. — V. 365. — P. 54-61.




Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта